My Cancer Experience
by Bob Riter
October 06, 2015

Related News

FDA Approves Beleodaq for Peripheral T-Cell Lymphoma

Jul 8, 2014

Drug designed to inhibit T cells from becoming cancerous

Risk of Diabetes Up in Hodgkin's Lymphoma Survivors

Aug 28, 2014

Para-aortic radiation with ≥36 Gy linked to increased risk of diabetes mellitus

FDA Approves Imbruvica for Mantle Cell Lymphoma

Nov 14, 2013

Drug designed to inhibit enzyme that cancer cells need to spread; granted "breakthrough therapy" status